unknown
Stage
1
Investors
About
Digi.Bio develops technology for digital nucleic acid diagnostics, enabling rapid and sensitive molecular testing on portable devices.
Explore Digi.Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.